25
Views
8
CrossRef citations to date
0
Altmetric
Review

Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy

&
Pages 393-401 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Manrique Alvarez, Eloy Roman, Edgardo S Santos & Luis E Raez. (2007) New targets for non-small-cell lung cancer therapy. Expert Review of Anticancer Therapy 7:10, pages 1423-1437.
Read now

Articles from other publishers (7)

Konstantinos Syrigos, Istvan Abert, Zoran Andric, Igor N Bondarenko, Mikhail Dvorkin, Kristina Galic, Rinat Galiulin, Vladimer Kuchava, Virote Sriuranpong, Dmytro Trukhin, Edvard Zhavrid, Dongyue Fu, Laurent M Kassalow, Stephanie Jones & Zahid Bashir. (2021) Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC). BioDrugs 35:4, pages 417-428.
Crossref
Lei Zhong, Jiao Yang, Zhixing Cao, Xin Chen, Yiguo Hu, Linli Li & Shengyong Yang. (2017) Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer. Oncotarget 8:8, pages 12843-12854.
Crossref
Chun-yang Zhang, Yu Qi, Xiang-nan Li, Yang Yang, Dong-lei Liu, Jia Zhao, Deng-yan Zhu, Kai Wu, Xu-dong Zhou & Song Zhao. (2015) The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients. Biomedicine & Pharmacotherapy 69, pages 242-248.
Crossref
Elena Galvani, Elisa Giovannetti, Francesca Saccani, Andrea Cavazzoni, Leticia G. Leon, Henk Dekker, Roberta Alfieri, Caterina Carmi, Marco Mor, Andrea Ardizzoni, Pier Giorgio Petronini & Godefridus J. Peters. (2013) Molecular Mechanisms Underlying the Antitumor Activity of 3-Aminopropanamide Irreversible Inhibitors of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer. Neoplasia 15:1, pages 61-IN18.
Crossref
Elena Galvani, Godefridus J Peters & Elisa Giovannetti. (2012) EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity. Future Oncology 8:8, pages 1015-1029.
Crossref
Massimo Di Maio, Ciro Gallo, Ermelinda De Maio, Alessandro Morabito, Maria Carmela Piccirillo, Cesare Gridelli & Francesco Perrone. (2010) Methodological aspects of lung cancer clinical trials in the era of targeted agents. Lung Cancer 67:2, pages 127-135.
Crossref
Suresh Ramalingam & Alan B. Sandler. (2006) Salvage Therapy for Advanced Non-Small Cell Lung Cancer: Factors Influencing Treatment Selection. The Oncologist 11:6, pages 655-665.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.